We are a leading global manufacturer of generic injectable medicines and we are building a strong market presence in Europe. Our high-quality manufacturing facilities in Portugal, Italy and Germany are EU approved and we have US FDA approval for our Portuguese and German plants. The facilities supply injectable products to the US, the Middle East and North Africa, and a growing number of markets in Europe.
Our products
We have a broad range of quality medicines and a growing pipeline of new, differentiated products.
Careers
We’re committed to our employees, our customers and the people they serve. Could you support one of our teams?
Related news
Hikma has launched Ritonavir Tablets USP
20 March 2018
Hikma announces global partnership with Direct Relief
15 March 2018
Hikma reports 2017 full year results
14 March 2018